FDA authorizes 1st COVID-19 pill to protect against severe disease

in the United States to protect against severe disease.

The authorization marks “a major step forward” in the pandemic, Dr. Patrizia Cavazzoni, director of the agency’s Center for Drug Evaluation and Research, said in a statement.“This authorization provides a new tool to combat COVID-19 at a crucial time in the pandemic as new variants emerge and promises to make antiviral treatment more accessible to patients who are at high risk for progression to severe COVID-19,” she said.

The new treatment could help ease the burden on hospitals as infections are expected to continue to surge this winter with the, already the dominant strain in the U.S. Initially, the supply of the drug is likely to be extremely limited, experts say.

Conspiracy theorists enter the room*

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

U.S. FDA set to authorize Pfizer, Merck COVID-19 pills this week - Bloomberg NewsThe U.S. Food and Drug Administration is set to authorize COVID-19 treatment pills from both Pfizer Inc and Merck as early as Wednesday, Bloomberg News reported on Tuesday, citing people familiar with the matter. Great; maybe Pfizer will increase the manufacturing dramatically. And it is effective against Omicron The problem will be a shortage A grossly insufficient supply of only 200,000 treatment courses now, and only 80 million expected by the end of 2022.
Source: Reuters - 🏆 2. / 97 Read more »